Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12964350rdf:typepubmed:Citationlld:pubmed
pubmed-article:12964350lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C0043240lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C0108092lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C1331418lld:lifeskim
pubmed-article:12964350lifeskim:mentionsumls-concept:C0991510lld:lifeskim
pubmed-article:12964350pubmed:issue7lld:pubmed
pubmed-article:12964350pubmed:dateCreated2003-9-10lld:pubmed
pubmed-article:12964350pubmed:abstractTextThis is a comparative study of a hydrocellular foam (Allevyn, Smith and Nephew) and a calcium alginate (Kaltostat, ConvaTec) in dressing split-thickness skin-graft donor sites. The dressing materials were used in equal halves of each donor site in 20 patients undergoing skin-graft harvest. The donor sites dressed with Allevyn showed a tendency to earlier healing, but this was not confirmed statistically. However, Allevyn was found to be more comfortable than Kaltostat and this difference was statistically significant. Due to its increased patient comfort, cheaper cost and comparable time to healing with Kaltostat, the authors recommend the use of Allevyn as a dressing for split-thickness skin-graft donor sites.lld:pubmed
pubmed-article:12964350pubmed:languageenglld:pubmed
pubmed-article:12964350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:citationSubsetNlld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12964350pubmed:statusMEDLINElld:pubmed
pubmed-article:12964350pubmed:monthJullld:pubmed
pubmed-article:12964350pubmed:issn0969-0700lld:pubmed
pubmed-article:12964350pubmed:authorpubmed-author:KingCClld:pubmed
pubmed-article:12964350pubmed:authorpubmed-author:SylaidisPPlld:pubmed
pubmed-article:12964350pubmed:authorpubmed-author:VaingankarN...lld:pubmed
pubmed-article:12964350pubmed:authorpubmed-author:ElenderFFlld:pubmed
pubmed-article:12964350pubmed:authorpubmed-author:EaglingVVlld:pubmed
pubmed-article:12964350pubmed:issnTypePrintlld:pubmed
pubmed-article:12964350pubmed:volume10lld:pubmed
pubmed-article:12964350pubmed:ownerNLMlld:pubmed
pubmed-article:12964350pubmed:authorsCompleteYlld:pubmed
pubmed-article:12964350pubmed:pagination289-91lld:pubmed
pubmed-article:12964350pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:meshHeadingpubmed-meshheading:12964350...lld:pubmed
pubmed-article:12964350pubmed:year2001lld:pubmed
pubmed-article:12964350pubmed:articleTitleComparison of hydrocellular foam and calcium alginate in the healing and comfort of split-thickness skin-graft donor sites.lld:pubmed
pubmed-article:12964350pubmed:affiliationDepartment of Plastic Surgery, West Norwich Hospital, Norwich, UK.lld:pubmed
pubmed-article:12964350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12964350pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12964350pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12964350lld:pubmed